There are some startling similarities developing between India and China. How many and how concerned investors should be will rank among the big questions in 2025.

China and India agreed on Wednesday to work on easing their long-running border dispute, as the two Asian giants resumed a formal high-level dialogue for the first time in five years.

Through cycles of stability and heightened tension China and India have learned that conflict undermines their long-term objectives.

"Your currency in the world is your track record, your relationships, and your trust. And China's hurting at all three.”

China and India have agreed to work toward a solution to their long-running border dispute in the Himalayas after a military standoff there that began with a deadly clash in 2020.

Analysts also believe the India-China rapprochement will not affect India’s strategic cooperation with the United States.

India is preparing to offer tariffs cuts on some farm and other goods mainly imported from the U.S., aiming to clinch a broader trade and investment deal once president-elect Donald Trump takes charge,

China and India should work harder to promote exchanges and bridge the perception gap between two countries, according to a leading Chinese expert on South Asia. Zhang Jiadong, director of the South Asian Studies Centre at Fudan University,

China's dominance in critical minerals poses supply chain vulnerabilities for India, US, and EU nations, requiring strategic diversification efforts.

Senior Indian and Chinese officials are set to meet in Beijing to discuss the two countries’ border dispute, resuming formal talks on the subject that have been stalled since 2020.

India's finished steel imports from China reached an all-time high during the first eight months of the fiscal year to March 2025, provisional government data showed, adding to concerns among domestic mills about cheap shipments from China.

CDMO giant Lonza unveiled plans to expand hard gelatin capsule production capacity at plants in India and China a week after announcing its intent to shed its capsules and health ingredients (CHI) division.